These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8559628)

  • 1. Cerebrospinal fluid shunt infections in children.
    Ronan A; Hogg GG; Klug GL
    Pediatr Infect Dis J; 1995 Sep; 14(9):782-6. PubMed ID: 8559628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.
    Parker SL; Attenello FJ; Sciubba DM; Garces-Ambrossi GL; Ahn E; Weingart J; Carson B; Jallo GI
    Childs Nerv Syst; 2009 Jan; 25(1):77-83; discussion 85. PubMed ID: 18985357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection.
    Simon TD; Kronman MP; Whitlock KB; Browd SR; Holubkov R; Kestle JRW; Kulkarni AV; Langley M; Limbrick DD; Luerssen TG; Oakes J; Riva-Cambrin J; Rozzelle C; Shannon CN; Tamber M; Wellons Iii JC; Whitehead WE; Mayer-Hamblett N;
    J Pediatric Infect Dis Soc; 2019 Jul; 8(3):235-243. PubMed ID: 29771360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters.
    Attenello FJ; Garces-Ambrossi GL; Zaidi HA; Sciubba DM; Jallo GI
    Neurosurgery; 2010 Feb; 66(2):284-9; discussion 289. PubMed ID: 20087127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components.
    Sciubba DM; Lin LM; Woodworth GF; McGirt MJ; Carson B; Jallo GI
    Neurosurg Focus; 2007 Apr; 22(4):E9. PubMed ID: 17613199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF shunt infections in pediatrics. A seven-year experience.
    Odio C; McCracken GH; Nelson JD
    Am J Dis Child; 1984 Dec; 138(12):1103-8. PubMed ID: 6507392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of complicated shunt infections: a clinical report.
    James HE; Bradley JS
    J Neurosurg Pediatr; 2008 Mar; 1(3):223-8. PubMed ID: 18352767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid shunt infections. A review of 35 infections in 32 patients.
    Forward KR; Fewer HD; Stiver HG
    J Neurosurg; 1983 Sep; 59(3):389-94. PubMed ID: 6886752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent cerebrospinal fluid shunt infection and the efficacy of reusing infected ventricular entry sites.
    Winston KR; Ho JT; Dolan SA
    J Neurosurg Pediatr; 2013 Jun; 11(6):635-42. PubMed ID: 23601015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of cerebrospinal fluid cell count and differential over a treatment course of shunt infection.
    Fulkerson DH; Sivaganesan A; Hill JD; Edwards JR; Shoja MM; Boaz JC; Jea A
    J Neurosurg Pediatr; 2011 Dec; 8(6):613-9. PubMed ID: 22132920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
    von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
    Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cerebrospinal fluid shunt infections: a decision analysis.
    Schreffler RT; Schreffler AJ; Wittler RR
    Pediatr Infect Dis J; 2002 Jul; 21(7):632-6. PubMed ID: 12237594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus influenzae infections of cerebrospinal fluid shunts. Report of two cases.
    Lerman SJ
    J Neurosurg; 1981 Feb; 54(2):261-3. PubMed ID: 6969789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.
    Test MR; Whitlock KB; Langley M; Riva-Cambrin J; Kestle JRW; Simon TD
    J Neurosurg Pediatr; 2019 Jul; 24(1):22-28. PubMed ID: 31051463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF shunt infections: a fifteen-year experience with emphasis on management and outcome.
    Morissette I; Gourdeau M; Francoeur J
    Can J Neurol Sci; 1993 May; 20(2):118-22. PubMed ID: 8334572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid shunt infection: a prospective study of risk factors.
    Kulkarni AV; Drake JM; Lamberti-Pasculli M
    J Neurosurg; 2001 Feb; 94(2):195-201. PubMed ID: 11213954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study.
    Pattavilakom A; Xenos C; Bradfield O; Danks RA
    J Clin Neurosci; 2007 Jun; 14(6):526-31. PubMed ID: 17430776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-negative cerebrospinal fluid shunt-associated infections.
    Sells CJ; Shurtleff DB; Loeser JD
    Pediatrics; 1977 Apr; 59(4):614-8. PubMed ID: 850601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections.
    Sciubba DM; McGirt MJ; Woodworth GF; Carson B; Jallo GI
    Childs Nerv Syst; 2007 Aug; 23(8):867-71. PubMed ID: 17387486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.